An interventional study of ST-IMRT SW-IMRT in Swallowing Dysfunction, sponsored by National Cancer Institute, Egypt. Status unknown at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-09-20.
Sponsored by National Cancer Institute, Egypt · Not applicable, Interventional, and Treatment
To clinically validate whether SW-IMRT actually reduce the occurrence of swallowing dysfunction as compared to ST-IMRT.
Patients are randomly assigned to either ST-IMRT or SW-IMRT.
2,344 studies on the registry are indexed under Head and Neck Neoplasms; 551 are open to participants now.
This study's enrollment of 146 is above the median of 47 across 1,751 interventional studies indexed under Head and Neck Neoplasms.
Browse Head and Neck Neoplasms studies →National Cancer Institute, Egypt is the lead sponsor of 133 studies on the registry; 29 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
standard parotid sparing IMRT
Radiation: ST-IMRT SW-IMRT
swallowing sparing IMRT
Radiation: ST-IMRT SW-IMRT
Subjective assessment of the swallowing function (dysphagia) at regular intervals
Subjective assessment of swallowing function (dysphagia) will be scored on a scale of 0 (no dysphagia) to 4 (life threatening consequences; urgent intervention indicated) each follow-up visit on the basis of National Cancer Institute Common Terminology Criteria for Adverse Events, version 4 (CTCAE 4).
Time frame: 6 months
Objective assessment of the swallowing function (dysphagia) at regular intervals
Objective assessment of swallowing will be made by videofluoroscopy and scored by Dynamic Imaging Grade of swallowing toxicity scale (DIGEST) and will be scored on a scale of 0 (no dysphagia) to 4 (life threatening )
Time frame: 6 months
local control
Clinical examination and Imaging will be done at regular interval to detect local or nodal recurrence
Time frame: 6 months
This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cancer Institute, Egypt